Annual CFF
$248.96 M
+$262.30 M+1966.69%
December 31, 2023
Summary
- As of February 7, 2025, RGEN annual cash flow from financing activities is $248.96 million, with the most recent change of +$262.30 million (+1966.69%) on December 31, 2023.
- During the last 3 years, RGEN annual CFF has fallen by -$56.95 million (-18.62%).
- RGEN annual CFF is now -48.65% below its all-time high of $484.87 million, reached on December 31, 2019.
Performance
RGEN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$69.60 M
-$63.83 M-1105.68%
September 30, 2024
Summary
- As of February 7, 2025, RGEN quarterly cash flow from financing activities is -$69.60 million, with the most recent change of -$63.83 million (-1105.68%) on September 30, 2024.
- Over the past year, RGEN quarterly CFF has dropped by -$68.83 million (-8846.53%).
- RGEN quarterly CFF is now -123.29% below its all-time high of $298.84 million, reached on December 31, 2020.
Performance
RGEN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$183.78 M
-$68.83 M-27.25%
September 30, 2024
Summary
- As of February 7, 2025, RGEN TTM cash flow from financing activities is $183.78 million, with the most recent change of -$68.83 million (-27.25%) on September 30, 2024.
- Over the past year, RGEN TTM CFF has increased by +$203.22 million (+1045.35%).
- RGEN TTM CFF is now -62.22% below its all-time high of $486.41 million, reached on March 31, 2020.
Performance
RGEN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RGEN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1966.7% | -8846.5% | +1045.3% |
| 3 y3 years | -18.6% | -10000.0% | -38.6% |
| 5 y5 years | +7207.3% | -123.6% | -62.1% |
RGEN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1966.7% | -126.0% | at low | -27.3% | +1045.3% |
| 5 y | 5-year | -48.6% | +1966.7% | -123.3% | at low | -62.2% | +1045.3% |
| alltime | all time | -48.6% | +1966.7% | -123.3% | at low | -62.2% | +1045.3% |
Repligen Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$69.60 M(+1105.7%) | $183.78 M(-27.2%) |
| Jun 2024 | - | -$5.77 M(-35.7%) | $252.60 M(+1.2%) |
| Mar 2024 | - | -$8.97 M(-103.3%) | $249.55 M(+0.2%) |
| Dec 2023 | $248.96 M(-1966.7%) | $268.13 M(<-9900.0%) | $248.96 M(-1380.7%) |
| Sep 2023 | - | -$778.00 K(-91.2%) | -$19.44 M(+11.7%) |
| Jun 2023 | - | -$8.82 M(-7.7%) | -$17.41 M(+60.0%) |
| Mar 2023 | - | -$9.56 M(+3390.1%) | -$10.88 M(-18.4%) |
| Dec 2022 | -$13.34 M(-1487.8%) | -$274.00 K(-121.9%) | -$13.34 M(+3.9%) |
| Sep 2022 | - | $1.25 M(-154.6%) | -$12.83 M(-9.7%) |
| Jun 2022 | - | -$2.29 M(-80.9%) | -$14.21 M(+22.8%) |
| Mar 2022 | - | -$12.02 M(-5303.9%) | -$11.57 M(-1303.6%) |
| Dec 2021 | $961.00 K(-99.7%) | $231.00 K(-289.3%) | $961.00 K(-99.7%) |
| Sep 2021 | - | -$122.00 K(-135.4%) | $299.57 M(-0.6%) |
| Jun 2021 | - | $345.00 K(-32.0%) | $301.37 M(-1.1%) |
| Mar 2021 | - | $507.00 K(-99.8%) | $304.83 M(-0.4%) |
| Dec 2020 | $305.92 M(-36.9%) | $298.84 M(>+9900.0%) | $305.92 M(+4334.9%) |
| Sep 2020 | - | $1.68 M(-56.0%) | $6.90 M(-97.7%) |
| Jun 2020 | - | $3.81 M(+140.0%) | $300.10 M(-38.3%) |
| Mar 2020 | - | $1.59 M(-982.8%) | $486.41 M(+0.3%) |
| Dec 2019 | $484.87 M(>+9900.0%) | -$180.00 K(-100.1%) | $484.87 M(-0.3%) |
| Sep 2019 | - | $294.88 M(+55.1%) | $486.09 M(+153.0%) |
| Jun 2019 | - | $190.13 M(>+9900.0%) | $192.10 M(+6061.0%) |
| Mar 2019 | - | $44.00 K(-95.8%) | $3.12 M(-8.5%) |
| Dec 2018 | $3.41 M(-97.4%) | $1.04 M(+18.1%) | $3.41 M(+27.8%) |
| Sep 2018 | - | $884.00 K(-22.9%) | $2.67 M(-98.0%) |
| Jun 2018 | - | $1.15 M(+244.1%) | $131.60 M(+0.8%) |
| Mar 2018 | - | $333.00 K(+9.9%) | $130.61 M(+0.5%) |
| Dec 2017 | $129.94 M(+15.9%) | $303.00 K(-99.8%) | $129.94 M(+0.3%) |
| Sep 2017 | - | $129.81 M(>+9900.0%) | $129.55 M(>+9900.0%) |
| Jun 2017 | - | $158.00 K(-147.9%) | $158.00 K(-99.9%) |
| Mar 2017 | - | -$330.00 K(+270.8%) | $111.46 M(-0.6%) |
| Dec 2016 | $112.11 M(>+9900.0%) | -$89.00 K(-121.2%) | $112.11 M(-0.0%) |
| Sep 2016 | - | $419.00 K(-99.6%) | $112.14 M(+0.2%) |
| Jun 2016 | - | $111.46 M(>+9900.0%) | $111.96 M(>+9900.0%) |
| Mar 2016 | - | $323.00 K(-629.5%) | $787.00 K(+2.6%) |
| Dec 2015 | $767.00 K(-54.3%) | -$61.00 K(-125.3%) | $767.00 K(-52.8%) |
| Sep 2015 | - | $241.00 K(-15.1%) | $1.63 M(+75.0%) |
| Jun 2015 | - | $284.00 K(-6.3%) | $929.10 K(-37.4%) |
| Mar 2015 | - | $303.00 K(-62.0%) | $1.49 M(-11.6%) |
| Dec 2014 | $1.68 M(-33.4%) | $798.00 K(-275.0%) | $1.68 M(+8.8%) |
| Sep 2014 | - | -$455.90 K(-154.3%) | $1.54 M(-15.4%) |
| Jun 2014 | - | $840.20 K(+68.8%) | $1.83 M(-11.5%) |
| Mar 2014 | - | $497.70 K(-24.9%) | $2.06 M(-18.2%) |
| Dec 2013 | $2.52 M(+117.6%) | $662.80 K(-477.9%) | $2.52 M(+18.3%) |
| Sep 2013 | - | -$175.40 K(-116.3%) | $2.13 M(-30.3%) |
| Jun 2013 | - | $1.08 M(+12.7%) | $3.06 M(+52.8%) |
| Mar 2013 | - | $956.70 K(+251.2%) | $2.00 M(+72.8%) |
| Dec 2012 | $1.16 M(-450.4%) | $272.40 K(-63.8%) | $1.16 M(+30.7%) |
| Sep 2012 | - | $751.70 K(+3412.6%) | $886.60 K(-552.6%) |
| Jun 2012 | - | $21.40 K(-81.1%) | -$195.90 K(-9.8%) |
| Mar 2012 | - | $113.50 K(-134.3%) | -$217.30 K(-46.6%) |
| Dec 2011 | -$330.80 K(+557.7%) | - | - |
| Sep 2011 | - | -$330.80 K(<-9900.0%) | -$406.80 K(+507.2%) |
| Jun 2011 | - | $0.00(-100.0%) | -$67.00 K(+33.5%) |
| Mar 2011 | -$50.30 K(+61.7%) | -$19.20 K(-66.2%) | -$50.20 K(+61.9%) |
| Dec 2010 | - | -$56.80 K(-731.1%) | -$31.00 K(+256.3%) |
| Dec 2010 | -$31.10 K(-368.1%) | - | - |
| Sep 2010 | - | $9000.00(-46.4%) | -$8700.00(-133.0%) |
| Jun 2010 | - | $16.80 K(>+9900.0%) | $26.40 K(+127.6%) |
| Mar 2010 | $11.60 K(-100.7%) | $0.00(-100.0%) | $11.60 K(-92.0%) |
| Dec 2009 | - | -$34.50 K(-178.2%) | $144.20 K(-109.5%) |
| Sep 2009 | - | $44.10 K(+2105.0%) | -$1.52 M(-16.9%) |
| Jun 2009 | - | $2000.00(-98.5%) | -$1.83 M(+14.5%) |
| Mar 2009 | -$1.60 M(-367.0%) | $132.60 K(-107.8%) | -$1.60 M(+5.4%) |
| Dec 2008 | - | -$1.70 M(+538.9%) | -$1.51 M(-489.0%) |
| Sep 2008 | - | -$265.40 K(-214.0%) | $389.20 K(-45.3%) |
| Jun 2008 | - | $232.90 K(+8.7%) | $711.30 K(+19.0%) |
| Mar 2008 | $597.70 K | $214.20 K(+3.2%) | $597.70 K(+14.8%) |
| Dec 2007 | - | $207.50 K(+266.0%) | $520.60 K(+86.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | $56.70 K(-52.5%) | $279.30 K(+16.7%) |
| Jun 2007 | - | $119.30 K(-13.0%) | $239.40 K(+102.7%) |
| Mar 2007 | $118.00 K(-64.5%) | $137.10 K(-505.6%) | $118.10 K(-55.5%) |
| Dec 2006 | - | -$33.80 K(-301.2%) | $265.30 K(-17.5%) |
| Sep 2006 | - | $16.80 K(-940.0%) | $321.70 K(-3.2%) |
| Jun 2006 | - | -$2000.00(-100.7%) | $332.40 K(-0.1%) |
| Mar 2006 | $332.50 K(+1193.8%) | $284.30 K(+1158.0%) | $332.60 K(+385.5%) |
| Dec 2005 | - | $22.60 K(-17.8%) | $68.50 K(+48.6%) |
| Sep 2005 | - | $27.50 K(-1627.8%) | $46.10 K(+129.4%) |
| Jun 2005 | - | -$1800.00(-108.9%) | $20.10 K(-21.8%) |
| Mar 2005 | $25.70 K(-99.8%) | $20.20 K(>+9900.0%) | $25.70 K(+295.4%) |
| Dec 2004 | - | $200.00(-86.7%) | $6500.00(-94.9%) |
| Sep 2004 | - | $1500.00(-60.5%) | $126.80 K(-9.0%) |
| Jun 2004 | - | $3800.00(+280.0%) | $139.30 K(-98.8%) |
| Mar 2004 | $11.98 M(>+9900.0%) | $1000.00(-99.2%) | $11.98 M(+0.0%) |
| Dec 2003 | - | $120.50 K(+760.7%) | $11.98 M(+1.0%) |
| Sep 2003 | - | $14.00 K(-99.9%) | $11.86 M(+0.1%) |
| Jun 2003 | - | $11.84 M(>+9900.0%) | $11.84 M(>+9900.0%) |
| Mar 2003 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2002 | - | $0.00(0.0%) | $1000.00(-91.4%) |
| Jun 2002 | - | $0.00(0.0%) | $11.60 K(-17.7%) |
| Mar 2002 | $14.10 K(-97.9%) | $0.00(-100.0%) | $14.10 K(-89.8%) |
| Dec 2001 | - | $1000.00(-90.6%) | $137.80 K(-29.2%) |
| Sep 2001 | - | $10.60 K(+324.0%) | $194.70 K(-15.3%) |
| Jun 2001 | - | $2500.00(-98.0%) | $229.80 K(-66.1%) |
| Mar 2001 | $677.10 K(-98.0%) | $123.70 K(+113.6%) | $677.00 K(-97.4%) |
| Dec 2000 | - | $57.90 K(+26.7%) | $25.78 M(+0.2%) |
| Sep 2000 | - | $45.70 K(-89.8%) | $25.72 M(+0.2%) |
| Jun 2000 | - | $449.70 K(-98.2%) | $25.67 M(-24.8%) |
| Mar 2000 | $34.13 M(>+9900.0%) | $25.23 M(>+9900.0%) | $34.13 M(+283.4%) |
| Dec 1999 | - | $0.00(-100.0%) | $8.90 M(0.0%) |
| Sep 1999 | - | -$5400.00(-100.1%) | $8.90 M(-0.1%) |
| Jun 1999 | - | $8.91 M(>+9900.0%) | $8.91 M(>+9900.0%) |
| Mar 1999 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1998 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1998 | - | $0.00(0.0%) | $2.00 M(0.0%) |
| Jun 1998 | - | $0.00(0.0%) | $2.00 M(0.0%) |
| Mar 1998 | $2.00 M(>+9900.0%) | $0.00(-100.0%) | $2.00 M(0.0%) |
| Dec 1997 | - | $2.00 M(>+9900.0%) | $2.00 M(>+9900.0%) |
| Sep 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1997 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 1996 | - | $0.00(0.0%) | -$4.60 M(0.0%) |
| Sep 1996 | - | $0.00(0.0%) | -$4.60 M(+4.5%) |
| Jun 1996 | - | $0.00(-100.0%) | -$4.40 M(+4.8%) |
| Mar 1996 | -$4.20 M(-625.0%) | -$4.60 M(<-9900.0%) | -$4.20 M(-940.0%) |
| Dec 1995 | - | $0.00(-100.0%) | $500.00 K(-54.5%) |
| Sep 1995 | - | $200.00 K(0.0%) | $1.10 M(+57.1%) |
| Jun 1995 | - | $200.00 K(+100.0%) | $700.00 K(-12.5%) |
| Mar 1995 | $800.00 K(-95.5%) | $100.00 K(-83.3%) | $800.00 K(-95.1%) |
| Dec 1994 | - | $600.00 K(-400.0%) | $16.30 M(-3.0%) |
| Sep 1994 | - | -$200.00 K(-166.7%) | $16.80 M(-4.5%) |
| Jun 1994 | - | $300.00 K(-98.1%) | $17.60 M(-1.7%) |
| Mar 1994 | $17.90 M(-18.3%) | $15.60 M(+1318.2%) | $17.90 M(+68.9%) |
| Dec 1993 | - | $1.10 M(+83.3%) | $10.60 M(-43.3%) |
| Sep 1993 | - | $600.00 K(0.0%) | $18.70 M(+1.6%) |
| Jun 1993 | - | $600.00 K(-92.8%) | $18.40 M(-16.0%) |
| Mar 1993 | $21.90 M(-11.0%) | $8.30 M(-9.8%) | $21.90 M(+59.9%) |
| Dec 1992 | - | $9.20 M(+2966.7%) | $13.70 M(+174.0%) |
| Sep 1992 | - | $300.00 K(-92.7%) | $5.00 M(-3.8%) |
| Jun 1992 | - | $4.10 M(+4000.0%) | $5.20 M(-78.9%) |
| Mar 1992 | $24.60 M(+115.8%) | $100.00 K(-80.0%) | $24.60 M(-0.4%) |
| Dec 1991 | - | $500.00 K(0.0%) | $24.70 M(+2.1%) |
| Sep 1991 | - | $500.00 K(-97.9%) | $24.20 M(+2.1%) |
| Jun 1991 | - | $23.50 M(>+9900.0%) | $23.70 M(+107.9%) |
| Mar 1991 | $11.40 M | $200.00 K(>+9900.0%) | $11.40 M(+1.8%) |
| Dec 1990 | - | $0.00(0.0%) | $11.20 M(0.0%) |
| Sep 1990 | - | $0.00(-100.0%) | $11.20 M(0.0%) |
| Jun 1990 | - | $11.20 M | $11.20 M |
FAQ
- What is Repligen annual cash flow from financing activities?
- What is the all time high annual CFF for Repligen?
- What is Repligen annual CFF year-on-year change?
- What is Repligen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Repligen?
- What is Repligen quarterly CFF year-on-year change?
- What is Repligen TTM cash flow from financing activities?
- What is the all time high TTM CFF for Repligen?
- What is Repligen TTM CFF year-on-year change?
What is Repligen annual cash flow from financing activities?
The current annual CFF of RGEN is $248.96 M
What is the all time high annual CFF for Repligen?
Repligen all-time high annual cash flow from financing activities is $484.87 M
What is Repligen annual CFF year-on-year change?
Over the past year, RGEN annual cash flow from financing activities has changed by +$262.30 M (+1966.69%)
What is Repligen quarterly cash flow from financing activities?
The current quarterly CFF of RGEN is -$69.60 M
What is the all time high quarterly CFF for Repligen?
Repligen all-time high quarterly cash flow from financing activities is $298.84 M
What is Repligen quarterly CFF year-on-year change?
Over the past year, RGEN quarterly cash flow from financing activities has changed by -$68.83 M (-8846.53%)
What is Repligen TTM cash flow from financing activities?
The current TTM CFF of RGEN is $183.78 M
What is the all time high TTM CFF for Repligen?
Repligen all-time high TTM cash flow from financing activities is $486.41 M
What is Repligen TTM CFF year-on-year change?
Over the past year, RGEN TTM cash flow from financing activities has changed by +$203.22 M (+1045.35%)